MedPath
HSA Approval

CEFTRIPHINE POWDER FOR INJECTION 1 g/vial

SIN12498P

CEFTRIPHINE POWDER FOR INJECTION 1 g/vial

CEFTRIPHINE POWDER FOR INJECTION 1 g/vial

January 10, 2004

SHOEI UNIVERSAL CORPORATION PTE LTD

SHOEI UNIVERSAL CORPORATION PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSHOEI UNIVERSAL CORPORATION PTE LTD
Licence HolderSHOEI UNIVERSAL CORPORATION PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, FOR SOLUTION

INTRAVENOUS, INTRAMUSCULAR

Medical Information

J01DD04

ceftriaxone

Manufacturer Information

SHOEI UNIVERSAL CORPORATION PTE LTD

DAE HAN NEW PHARM. CO. LTD.

Active Ingredients

CEFTRIAXONE SODIUM

1 g/vial

Ceftriaxone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CEFTRIPHINE POWDER FOR INJECTION 1 g/vial - HSA Approval | MedPath